CPHI Milan
Published on March 11, 2024
Schedule a meeting, or stop by stand #18h11 to discuss your complex biologic or bioconjugate program with our experts during CPHI Milan 2024
We welcome the opportunity to schedule some time to connect on your project-specific needs and to provide you with an update on our expanded global capabilities. From antibodies (mAbs) to recombinant vaccines and bioconjugates- including ADCs, radioconjugates, and oligonucleotides, our team appreciates the chance to share how Abzena can assist in moving your program forward faster to its next milestone.
Our team of experienced experts will include:
- CCO, Joseph Principe
- Chief Technical and Quality Office, Louise Duffy
- SVP & Scientific Leader, Dr. Petra Dieterich
- SVP of Global Marketing, Kimberly Burrell
- VP, Research and Innovation, Rob Holgate
- VP of Strategy, Gavin Murdoch
- Head of EU/ROW Sales, Jonathan Cruikshank
- VP of Business Development, Roger Bowie
- VP of Business Development, Patrick Haddad
- VP of Business Development, Gildas Lavenant
Schedule a Meeting with Our Team!
Event Information:
Fiera Milano, Italy
October 8-10, 2024
The post CPHI Milan appeared first on abzena.